Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer - Reply

被引：1
|
作者：
Sabbatini, Paul
Odunsi, Kunle
机构：
[1] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, New York, NY 10021 USA
[2] Roswell Pk Canc Inst, Div Gynecol Oncol, Buffalo, NY 14263 USA
来源：
CLINICAL CANCER RESEARCH | 2007年 / 13卷 / 13期
关键词：
D O I：
10.1158/1078-0432.CCR-07-0718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4026 / 4027
页数：2
相关论文
共 50 条
  • [31] Phase I trial of intravenous docetaxel and intraperitoneal oxaliplatin in recurrent ovarian, fallopian tube and primary peritoneal cancer
    Zorn, K.
    Donovan, H.
    Zamboni, W.
    Edwards, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S134 - S134
  • [32] Phase I study of intraveneous docetaxel and intraperitoneal oxaliplatin in recurrent ovarian, fallopian tube and peritoneal cancer
    Taylor, Sarah E.
    Li, Ruosha
    Petschauer, Jennifer S.
    Donovan, Heidi
    Zamboni, William C.
    Edwards, Robert P.
    Zorn, Kristen K.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Results from a phase I study demonstrate the safety and immunogenicity of a peptide-based vaccine for patients with epithelial ovarian, Fallopian tube, or primary peritoneal carcinoma
    Chianese-Bullock, Kimberly A.
    Irvin, William P.
    Petroni, Gina R.
    Murphy, Cheryl
    Smolkin, Mark
    Olson, Walter
    Coleman, Elizabeth
    Boerner, Scott
    Nail, Carmel J.
    Hodges, Jennifer
    Neese, Patrice Y.
    Yuan, Arlene
    Hogan, Kevin T.
    Slingluff, Craig L.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 892 - 892
  • [34] EFFECTIVENESS OF ORAL ETOPOSIDE IN RECURRENT OR REFRACTORY EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CANCER AND FALLOPIAN TUBE CANCER
    Kongsawatvorakul, C.
    Charakorn, C.
    Chittithaworn, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 742 - 742
  • [35] Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer
    Kongsawatvorakul, Chompunoot
    Charakorn, Chuenkamon
    Chittithaworn, Suwicha
    Lertkhachonsuk, Arb-Aroon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2331 - 2335
  • [36] Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Fu, Siqing
    Corr, Bradley R.
    Culm-Merdek, Kerry
    Mockbee, Colleen
    Youssoufian, Hagop
    Stagg, Robert
    Naumann, R. Wendel
    Wenham, Robert M.
    Rosengarten, Rafael D.
    Benjamin, Laura
    Hamilton, Erika Paige
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2568 - +
  • [37] Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer
    Coleman, Robert L.
    Duska, Linda R.
    Ramirez, Pedro T.
    Heymach, John V.
    Kamat, Aparna A.
    Modesitt, Susan C.
    Schmeler, Kathleen M.
    Iyer, Revathy B.
    Garcia, Michael E.
    Miller, Debbie L.
    Jackson, Edward F.
    Ng, Chaan S.
    Kundra, Vikas
    Jaffe, Robert
    Sood, Anil K.
    LANCET ONCOLOGY, 2011, 12 (12): : 1109 - 1117
  • [38] A multicentre phase II study of AZD1775 plus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Moore, K. N.
    Cadoo, K. A.
    Chambers, S.
    Ghamande, S.
    Konecny, G.
    Oza, A. M.
    Chen, L-M.
    Konstantinopoulos, P. A.
    Lea, J.
    Spitz, D.
    Uyar, D.
    Mugundu, G.
    Laing, N.
    Strickland, D. K.
    Jones, S.
    Burris, H.
    Spigel, D. R.
    Hamilton, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
    Myong Cheol Lim
    Young-Joo Won
    Jiwon Lim
    Tahereh Salehi
    Chong Woo Yoo
    Robert E. Bristow
    BMC Cancer, 18
  • [40] Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
    Lim, Myong Cheol
    Won, Young-Joo
    Lim, Jiwon
    Salehi, Tahereh
    Yoo, Chong Woo
    Bristow, Robert E.
    BMC CANCER, 2018, 18
12345